{"id":"13255768-1bd2-56ee-aeff-873bd4de6baf","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-human-muscle-lipid","predicate":"reduces","statement":"Subjects randomized to chromium had lower intramyocellular lipid measurements in the substudy.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"f6c4e234-9e37-5f11-92e1-5ae5f632de10","mechanism_event_label":"A muscle-lipid measurement changed, offering a possible research lead rather than a proven universal mediator.","subject":{"id":"1d98d864-31cb-5d4f-a587-2b0eb692faa0","slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"},"object":{"id":"b4a01c98-2e53-5f8c-9c7a-3a320031c62a","slug":"intramyocellular-lipid-content","display_name":"Intramyocellular lipid content","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"f6c4e234-9e37-5f11-92e1-5ae5f632de10","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-human-muscle-lipid-event","event_type":"observed_intervention","label":"A muscle-lipid measurement changed, offering a possible research lead rather than a proven universal mediator.","description":"Subjects randomized to chromium had lower intramyocellular lipid measurements in the substudy.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"1d98d864-31cb-5d4f-a587-2b0eb692faa0","slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b4a01c98-2e53-5f8c-9c7a-3a320031c62a","slug":"intramyocellular-lipid-content","display_name":"Intramyocellular lipid content","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/chromium-research/20022616.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"0c9e6d805526dd6fa08c3a57f750df6d1f2312932e04ea8c3ce7975f46d65ab2\", \"start_char\": 0, \"end_char\": 1864, \"text_sha256\": \"0c9e6d805526dd6fa08c3a57f750df6d1f2312932e04ea8c3ce7975f46d65ab2\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Randomized supplementation with euglycemic-clamp and tissue-lipid substudy","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"1,000 µg chromium/day or placebo; responders classified by ≥10% change in insulin sensitivity","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Response-defined subgroup comparisons can be affected by regression to the mean and post-treatment selection. They do not validate a deficiency test or a prospective rule for choosing treatment.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Chromium research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Human with type 2 diabetes across a range of phenotypes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A muscle-lipid measurement changed, offering a possible research lead rather than a proven universal mediator.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[chromium-p20022616] Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. (2010). https://pubmed.ncbi.nlm.nih.gov/20022616/ DOI: 10.1016/j.metabol.2009.09.023","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Insulin sensitivity, muscle/liver lipid and chromium measurements","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"0fdc6cb6-4b58-5f1a-b13c-8a829e051a0e","evidence_kind":"source_excerpt","locator":"Lines 1095-1106","start_line":1095,"end_line":1106,"excerpt":"### chromium-human-muscle-lipid\nSubjects randomized to chromium had lower intramyocellular lipid measurements in the substudy.\nCondition category: normal\nnutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: A muscle-lipid measurement changed, offering a possible research lead rather than a proven universal mediator.\norganism: Human with type 2 diabetes across a range of phenotypes\ntissue_or_cell_type: Insulin sensitivity, muscle/liver lipid and chromium measurements\nexperimental_model: Randomized supplementation with euglycemic-clamp and tissue-lipid substudy\nlimitations: Response-defined subgroup comparisons can be affected by regression to the mean and post-treatment selection. They do not validate a deficiency test or a prospective rule for choosing treatment.\nexposure: 1,000 µg chromium/day or placebo; responders classified by ≥10% change in insulin sensitivity\nevidence_span: {\"source_cache\": \"artifacts/chromium-research/20022616.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"0c9e6d805526dd6fa08c3a57f750df6d1f2312932e04ea8c3ce7975f46d65ab2\", \"start_char\": 0, \"end_char\": 1864, \"text_sha256\": \"0c9e6d805526dd6fa08c3a57f750df6d1f2312932e04ea8c3ce7975f46d65ab2\"}\n[chromium-p20022616] Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. (2010). https://pubmed.ncbi.nlm.nih.gov/20022616/ DOI: 10.1016/j.metabol.2009.09.023","model_system":"Randomized supplementation with euglycemic-clamp and tissue-lipid substudy","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [chromium-p20022616] Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. (2010). https://pubmed.ncbi.nlm.nih.gov/20022616/ DOI: 10.1016/j.metabol.2009.09.023","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"fa96342a-ca01-5425-98d9-d50e29bf0abd","stable_key":"import-4d8e4781-3878-5818-8d0a-7dbd6e024555","title":"Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"6cae22f9104c6de041b25c23b0fd2884cc57707ac0c9a87c20b0e665d16de5ab","revision_id":"22893798-8329-5295-9c9d-82169032fc79","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}